Federal Register / Vol. 89, No. 24 / Monday, February 5, 2024 / Notices 7715 

Counselors, National Institute for 

Occupational Safety and Health, Centers 

for Disease Control and Prevention, 

Constitution Center, 400 7th Street SW, 

Suite 5W, Washington, District of 

Columbia 20024. Telephone: (202) 245– 

0649; Email: MStrickland2@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Background: The Secretary of Health 

and Human Services, the Assistant 

Secretary for Health, and by delegation 

the Director, Centers for Disease Control 

and Prevention, are authorized under 

Sections 301 and 308 of the Public 

Health Service Act to conduct directly, 

or by grants or contracts, research, 

experiments, and demonstrations 

relating to occupational safety and 

health and to mine health. 

Purpose: The Board of Scientific 

Counselors, National Institute for 

Occupational Safety and Health (BSC, 

NIOSH) provides advice to the Director, 

National Institute for Occupational 

Safety and Health, on NIOSH research 

and prevention programs. The Board 

also provides guidance on the Institute’s 

research activities related to developing 

and evaluating hypotheses, 

systematically documenting findings, 

and disseminating results. In addition, 

the Board evaluates the degree to which 

the activities of NIOSH: (1) conform to 

those standards of scientific excellence 

appropriate for Federal scientific 

institutions in accomplishing objectives 

in occupational safety and health; (2) 

address currently relevant needs in the 

fields of occupational safety and health 

either alone or in conjunction with 

other known activities inside and 

outside of NIOSH; and (3) produce their 

intended results in addressing 

important research questions in 

occupational safety and health, both in 

terms of applicability of the research 

findings and dissemination of the 

findings. 

Matters To Be Considered: The agenda 

for the meeting addresses the NIOSH 

Evaluation Capacity Building Plan (ECB 

Plan) and Scoring Progress on the ECB 

Plan; Diversity, Equity, and Inclusion at 

NIOSH; and a National Firefighter 

Registry Subcommittee Update. Agenda 

items are subject to change as priorities 

dictate. 

The agenda is also posted on the 

NIOSH website at https://www.cdc.gov/ 

niosh/bsc/. 

Public Participation 

Written Public Comment: Written 

comments will be accepted per the 

instructions provided in the addresses 

section above. Comments received in 

advance of the meeting are part of the 

public record and are subject to public 

disclosure. Written comments will be 

included in the official record of the 

meeting. Do not include any 

information in your comment or 

supporting materials that you consider 

confidential or inappropriate for public 

disclosure. If you include your name, 

contact information, or other 

information that identifies you in the 

body of your comments, that 

information will be on public display. 

CDC will review all submissions and 

may choose to redact, or withhold, 

submissions containing private or 

proprietary information such as Social 

Security numbers, medical information, 

inappropriate language, or duplicate/ 

near-duplicate examples of a mass-mail 

campaign. CDC will carefully consider 

all comments submitted into the docket. 

Written comments received by March 

6, 2024, will be provided to the Board 

prior to the meeting. 

Oral Public Comment: The public is 

welcome to participate during the 

public comment period, from 1 p.m. to 

1:15 p.m., EDT, March 13, 2024. Each 

commenter will be provided up to five 

minutes for comment. A limited number 

of time slots are available and will be 

assigned on a first-come, first-served 

basis. Members of the public who wish 

to address the BSC, NIOSH are 

requested to contact the Designated 

Federal Officer for scheduling purposes 

(see FOR FURTHER INFORMATION CONTACT

above). 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–02180 Filed 2–2–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–24–0728] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled ‘‘National 

Notifiable Diseases Surveillance System 

(NNDSS)’’ to the Office of Management 

and Budget (OMB) for review and 

approval. CDC previously published a 

‘‘Proposed Data Collection Submitted 

for Public Comment and 

Recommendations’’ notice on November 

14, 2023 to obtain comments from the 

public and affected agencies. CDC 

received one comment related to the 

previous notice. This notice serves to 

allow an additional 30 days for public 

and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 


lotter on DSK11XQN23PROD with NOTICES1
7716 Federal Register / Vol. 89, No. 24 / Monday, February 5, 2024 / Notices 

Proposed Project 

National Notifiable Diseases 

Surveillance System (NNDSS) (OMB 

Control No. 0920–0728, Exp. 03/31/ 

2026)—Revision—Office of Public 

Health Data, Surveillance, and 

Technology (OPHDST), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

The Public Health Services Act (42 

U.S.C. 241) authorizes CDC to 

disseminate nationally notifiable 

condition information. The National 

Notifiable Diseases Surveillance System 

(NNDSS) is based on data collected at 

the state, territorial and local levels 

because of legislation and regulations in 

those jurisdictions that require health 

care providers, medical laboratories, 

and other entities to submit healthrelated data on reportable conditions to 

public health departments. These 

reportable conditions, which include 

infectious and non-infectious diseases, 

vary by jurisdiction depending upon 

each jurisdiction’s health priorities and 

needs. Each year, the Council of State 

and Territorial Epidemiologists (CSTE), 

supported by CDC, determines which 

reportable conditions should be 

designated nationally notifiable or 

under standardized surveillance. CDC 

requests a three-year approval for a 

Revision of the NNDSS (OMB Control 

No. 0920–0728, Exp. Date 03/31/2026). 

This Revision includes requests for 

approval to: (1) receive case notification 

data for Cronobacter and Ehrlichiosis, 

new notifiable conditions; (2) receive 

case notification data for Congenital 

cytomegalovirus infection and 

Toxoplasmosis, new conditions under 

standardized surveillance; and (3) 

receive new disease-specific data 

elements for Cronobacter, Hansen’s 

Disease (Leprosy), and Leptospirosis. 

The NNDSS currently facilitates the 

submission and aggregation of case 

notification data voluntarily submitted 

to CDC from 60 jurisdictions: public 

health departments in every U.S. state, 

New York City, Washington DC, five 

U.S. territories (American Samoa, the 

Commonwealth of Northern Mariana 

Islands, Guam, Puerto Rico, and the U.S. 

Virgin Islands), and three freely 

associated states (Federated States of 

Micronesia, the Republic of the 

Marshall Islands, and the Republic of 

Palau). This information is shared 

across jurisdictional boundaries and 

both surveillance and prevention and 

control activities are coordinated at 

regional and national levels. 

Approximately 90% of case 

notifications are encrypted and 

submitted to NNDSS electronically from 

already existing databases by automated 

electronic messages. When automated 

transmission is not possible, case 

notifications are faxed, emailed, 

uploaded to a secure network or entered 

into a secure website. All case 

notifications that are faxed or emailed 

are done so in the form of an aggregate 

weekly or annual report, not individual 

cases. These different mechanisms used 

to send case notifications to CDC vary 

by the jurisdiction and the disease or 

condition. Jurisdictions remove most 

personally identifiable information (PII) 

before data are submitted to CDC, but 

some data elements (e.g., date of birth, 

date of diagnosis, county of residence) 

could potentially be combined with 

other information to identify 

individuals. Private information is not 

disclosed unless otherwise compelled 

by law. All data are treated in a secure 

manner consistent with the technical, 

administrative, and operational controls 

required by the Federal Information 

Security Management Act of 2002 

(FISMA) and the 2010 National Institute 

of Standards and Technology (NIST) 

Recommended Security Controls for 

Federal Information Systems and 

Organizations. Weekly tables of 

nationally notifiable diseases are 

available through CDC WONDER and 

data.cdc.gov. Annual summaries of 

finalized nationally notifiable disease 

data are published on CDC WONDER 

and data.cdc.gov and disease-specific 

data are published by individual CDC 

programs. 

The burden estimates include the 

number of hours that the public health 

department uses to process and send 

case notification data from their 

jurisdiction to CDC. Specifically, the 

burden estimates include separate 

burden hours incurred for automated 

and non-automated transmissions, 

separate weekly burden hours incurred 

for modernizing surveillance systems as 

part of CDC’s Data Modernization 

Initiative (DMI) implementation, 

separate burden hours incurred for 

annual data reconciliation and 

submission, and separate one-time 

burden hours incurred for the addition 

of new diseases and data elements. The 

burden estimates for the one-time 

burden for reporting jurisdictions are for 

the addition of case notification data for 

Cronobacter and Ehrlichiosis, new 

notifiable conditions; the addition of 

case notification data for Congenital 

cytomegalovirus infection and 

Toxoplasmosis, new conditions under 

standardized surveillance; and the 

addition of new disease-specific data 

elements for Cronobacter, Hansen’s 

Disease (Leprosy) and Leptospirosis. 

The estimated annual burden for the 

257 respondents is 18,414 hours. The 

total burden hours decreased from 

18,594 to 18,414 since the last Revision 

because there were fewer diseasespecific data elements added compared 

to the previous Revision. There are no 

costs to respondents other than their 

time to participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

States ............................................ Weekly (Automated) ......................................................... 50 52 20/60 

States ............................................ Weekly (Non-automated) .................................................. 10 52 2 

States ............................................ Weekly (DMI Implementation) .......................................... 50 52 4 

States ............................................ Annual ............................................................................... 50 1 75 

States ............................................ One-time Addition of Diseases and Data Elements ........ 50 1 3 

Territories ...................................... Weekly (Automated) ......................................................... 5 52 20/60 

Territories ...................................... Weekly, Quarterly (Non-automated) ................................. 5 56 20/60 

Territories ...................................... Weekly (DMI Implementation) .......................................... 5 52 4 

Territories ...................................... Annual ............................................................................... 5 1 5 

Territories ...................................... One-time Addition of Diseases and Data Elements ........ 5 1 3 

Freely Associated States .............. Weekly (Automated) ......................................................... 3 52 20/60 

Freely Associated States .............. Weekly, Quarterly (Non-automated) ................................. 3 56 20/60 

Freely Associated States .............. Annual ............................................................................... 3 1 5 

Freely Associated States .............. One-time Addition of Diseases and Data Elements ........ 3 1 3 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 89, No. 24 / Monday, February 5, 2024 / Notices 7717 

ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Cities ............................................. Weekly (Automated) ......................................................... 2 52 20/60 

Cities ............................................. Weekly (Non-automated) .................................................. 2 52 2 

Cities ............................................. Weekly (DMI Implementation) .......................................... 2 52 4 

Cities ............................................. Annual ............................................................................... 2 1 75 

Cities ............................................. One-time Addition of Diseases and Data Elements ........ 2 1 3 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2024–02171 Filed 2–2–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP)—CE24–011, 

Grants To Support New Investigators 

in Conducting Research Related To 

Understanding Drug Use and 

Overdose Risk and Protective Factors 

(K01); Cancellation of Meeting 

AGENCY: Centers for Disease Control and 

Prevention, Department of Health and 

Human Services. 

ACTION: Notice. 

FOR FURTHER INFORMATION CONTACT: 

Aisha L. Wilkes, M.P.H., Scientific 

Review Officer, National Center for 

Injury Prevention and Control, Centers 

for Disease Control and Prevention, 

4770 Buford Highway NE, Mailstop 

S106–9, Atlanta, Georgia 30341–3717. 

Telephone: (404) 639–6473; Email: 

AWilkes@cdc.gov. 

SUPPLEMENTARY INFORMATION: Notice is 

hereby given of a change in the meeting 

of the Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP)—CE24–011, 

Grants to Support New Investigators in 

Conducting Research Related to 

Understanding Drug Use and Overdose 

Risk and Protective Factors (K01); 

Cancellation of Meeting; March 5, 2024, 

8:30 a.m.–5 p.m., EST., in the original 

Federal Register notice FRN. The web 

conference was published in the 

Federal Register on Tuesday, October 

24, 2023, 88 FR 73020. 

This meeting is being canceled in its 

entirety. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–02208 Filed 2–2–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day-24–0696; Docket No. CDC–2024– 

0006] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a continuing information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a proposed information 

collection project titled National HIV 

Prevention Program Monitoring and 

Evaluation (NHM&E). NHM&E collects 

standardized HIV prevention program 

evaluation data from health departments 

and community-based organizations 

(CBOs) who receive federal funds for 

HIV prevention activities. 

DATES: CDC must receive written 

comments on or before April 5, 2024. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2024– 

0006 by either of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

www.regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(www.regulations.gov) or by U.S. mail to 

the address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; 

Telephone: 404–639–7118; Email: omb@

cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 


lotter on DSK11XQN23PROD with NOTICES1